腎細胞癌の薬効マーカー

• 收藏
• 分享

专利权人:

塩野義製薬株式会社

发明人:

澤田 拓子,中村 祐輔,前佛 均,水守 理

申请号：

JP2010101608

公开号：

JP5721342B2

申请日:

2010.04.27

申请国别(地区):

JP

年份:

2015

代理人:

摘要：

PROBLEM TO BE SOLVED: To provide a method of sorting out patients to whom interleukin-2 (IL-2) and interferon alpha (IFN-alpha) concurrent treatment are effective for treating of renal cell carcinoma, and to provide a useful reagent and a useful reagent kit in order to easily carry out the above method.SOLUTION: Sensitivity of the patient over renal cell carcinoma IL-2 and IFN-alpha concurrent treatment is detected by the expression amount of either or both HLA-DQA1 gene and HLA-DQB1 gene as an indicator.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/